Almac

Almac understands the critical timelines in drug development and the key advantages our clients gain in significantly reducing development timelines through achieving milestones earlier, minimising cash-burn, quicker return on investment and gaining competitive advantage.

rapidd™ offers flexible solutions for acceleration of entry into early clinical development. rapidd™ is a lean, efficient, integrated package from selection of pre-clinical candidate to Phase I regulatory submission.

Almac, in collaboration with selected CROs, provides world class talent delivering a unique drug development package leading to completion of Phase I regulatory submission in under 12 months.